Early immune response in post endoscopic retrograde cholangiopancreatography pancreatitis as a model for acute pancreatitis
|
摘要
This opinion review summarizes comparison of clinical presentation and immunology of post-endoscopic pancreatitis and acute pancreatitis(AP) of other etiology.The rationale for this topic was found in studies that mention differences in clinical presentation between these entities,stating that severe form of AP after endoscopic retrograde cholangiopancreatography was more severe than AP of other etiology.Found difference in clinical presentation may have a background in different immunology that needs to be further investigated.
This opinion review summarizes comparison of clinical presentation and immunology of post-endoscopic pancreatitis and acute pancreatitis(AP) of other etiology.The rationale for this topic was found in studies that mention differences in clinical presentation between these entities,stating that severe form of AP after endoscopic retrograde cholangiopancreatography was more severe than AP of other etiology.Found difference in clinical presentation may have a background in different immunology that needs to be further investigated.
This opinion review summarizes comparison of clinical presentation and immunology of post-endoscopic pancreatitis and acute pancreatitis(AP) of other etiology.The rationale for this topic was found in studies that mention differences in clinical presentation between these entities,stating that severe form of AP after endoscopic retrograde cholangiopancreatography was more severe than AP of other etiology.Found difference in clinical presentation may have a background in different immunology that needs to be further investigated.
引文
1 Tenner S,Baillie J,DeWitt J,Vege SS;American College of Gastroenterology.American College of Gastroenterology guideline:management of acute pancreatitis.Am J Gastroenterol 2013;108:1400-15;1416[PMID:23896955 DOI:10.1038/ajg.2013.218]
2 Dumonceau JM,Andriulli A,Elmunzer BJ,Mariani A,Meister T,Deviere J,Marek T,Baron TH,Hassan C,Testoni PA,Kapral C;European Society of Gastrointestinal Endoscopy.Prophylaxis of post-ERCPpancreatitis:European Society of Gastrointestinal Endoscopy(ESGE)Guideline-updated June 2014.Endoscopy 2014;46:799-815[PMID:25148137 DOI:10.1055/s-0034-1377875]
3 Testoni PA,Vailati C,Giussani A,Notaristefano C,Mariani A.ERCP-induced and non-ERCP-induced acute pancreatitis:Two distinct clinical entities with different outcomes in mild and severe form?Dig Liver Dis 2010;42:567-570[PMID:20018574 DOI:10.1016/j.dld.2009.10.008]
4 Sinha A,Cader R,Akshintala VS,Hutfless SM,Zaheer A,Khan VN,Khashab MA,Lennon AM,Kalloo AN,Singh VK.Systemic inflammatory response syndrome between 24 and 48 h after ERCP predicts prolonged length of stay in patients with post-ERCP pancreatitis:a retrospective study.Pancreatology2015;15:105-110[PMID:25728146 DOI:10.1016/j.pan.2015.02.005]
5 Plavsic I,?itini?I,Mikolasevic I,Poropat G,Hauser G.Endoscopic retrograde cholangiopancreatography-induced and non-endoscopic retrograde cholangiopancreatography-induced acute pancreatitis:Two distinct clinical and immunological entities?World J Gastrointest Endosc 2018;10:259-266[PMID:30364685 DOI:10.4253/wjge.v10.i10.259]
6 Messmann H,Vogt W,Holstege A,Lock G,Heinisch A,von Fürstenberg A,Leser HG,Zirngibl H,Sch?lmerich J.Post-ERP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis.Gut 1997;40:80-85[PMID:9155580 DOI:10.1136/gut.40.1.80]
7 Minkov GA,Halacheva KS,Yovtchev YP,Gulubova MV.Pathophysiological mechanisms of acute pancreatitis define inflammatory markers of clinical prognosis.Pancreas 2015;44:713-717[PMID:26061557 DOI:10.1097/MPA.0000000000000329]
8 Pérez S,Pereda J,Sabater L,Sastre J.Redox signaling in acute pancreatitis.Redox Biol 2015;5:1-14[PMID:25778551 DOI:10.1016/j.redox.2015.01.014]
9 Kilciler G,Musabak U,Bagci S,Yesilova Z,Tuzun A,Uygun A,Gulsen M,Oren S,Oktenli C,Karaeren N.Do the changes in the serum levels of IL-2,IL-4,TNFalpha,and IL-6 reflect the inflammatory activity in the patients with post-ERCP pancreatitis?Clin Dev Immunol 2008;2008:481560[PMID:18670651DOI:10.1155/2008/481560]
10 Concepción-Martín M,Gómez-Oliva C,Juanes A,Mora J,Vidal S,Díez X,Torras X,Sainz S,Villanueva C,FarréA,Guarner-Argente C,Guarner C.IL-6,IL-10 and TNFαdo not improve early detection of post-endoscopic retrograde cholangiopancreatography acute pancreatitis:a prospective cohort study.Sci Rep 2016;6:33492[PMID:27642079 DOI:10.1038/srep33492]
11 Fung AS,Tsiotos GG,Sarr MG.ERCP-induced acute necrotizing pancreatitis:is it a more severe disease?Pancreas 1997;15:217-221[PMID:9336783 DOI:10.1097/00006676-199710000-00001]
12 Abid GH,Siriwardana HP,Holt A,Ammori BJ.Mild ERCP-induced and non-ERCP-related acute pancreatitis:two distinct clinical entities?J Gastroenterol 2007;42:146-151[PMID:17351804 DOI:10.1007/s00535-006-1979-7]
13 Mentula P,Kyl?np??-B?ck ML,Kemppainen E,Takala A,Jansson SE,Kautiainen H,Puolakkainen P,Haapiainen R,Repo H.Decreased HLA(human leucocyte antigen)-DR expression on peripheral blood monocytes predicts the development of organ failure in patients with acute pancreatitis.Clin Sci(Lond)2003;105:409-417[PMID:12780344 DOI:10.1042/CS20030058]
14 Pezzilli R,Billi P,Gullo L,Beltrandi E,Maldini M,Mancini R,Incorvaia L,Miglioli M.Behavior of serum soluble interleukin-2 receptor,soluble CD8 and soluble CD4 in the early phases of acute pancreatitis.Digestion 1994;55:268-273[PMID:8063032 DOI:10.1159/000201159]
15 Demols A,Deviere J.New frontiers in the pharmacological prevention of post-ERCP pancreatitis:the cytokines.JOP 2003;4:49-57[PMID:12555016]
16 Dabrowski A,Osada J,Dabrowska MI,Wereszczynska-Siemiatkowska U.Monocyte subsets and natural killer cells in acute pancreatitis.Pancreatology 2008;8:126-134[PMID:18382098 DOI:10.1159/000123605]
17 Mentula P,Kyl?np??ML,Kemppainen E,Jansson SE,Sarna S,Puolakkainen P,Haapiainen R,Repo H.Early prediction of organ failure by combined markers in patients with acute pancreatitis.Br J Surg 2005;92:68-75[PMID:15521080 DOI:10.1002/bjs.4786]
18 Devière J,Le Moine O,Van Laethem JL,Eisendrath P,Ghilain A,Severs N,Cohard M.Interleukin 10reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography.Gastroenterology 2001;120:498-505[PMID:11159890 DOI:10.1053/gast.2001.21172]
19 Dumot JA,Conwell DL,Zuccaro G,Vargo JJ,Shay SS,Easley KA,Ponsky JL.A randomized,double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis.Am J Gastroenterol 2001;96:2098-2102[PMID:11467638 DOI:10.1111/j.1572-0241.2001.04092.x]
20 Norman JG,Fink G,Franz M,Guffey J,Carter G,Davison B,Sexton C,Glaccum M.Active interleukin-1 receptor required for maximal progression of acute pancreatitis.Ann Surg 1996;223:163-169[PMID:8597510 DOI:10.1097/00000658-199602000-00008]
21 Brivet FG,Emilie D,Galanaud P.Pro-and anti-inflammatory cytokines during acute severe pancreatitis:an early and sustained response,although unpredictable of death.Parisian Study Group on Acute Pancreatitis.Crit Care Med 1999;27:749-755[PMID:10321665 DOI:10.1097/00003246-199904000-00029]
22 Akinosoglou K,Gogos C.Immune-modulating therapy in acute pancreatitis:fact or fiction.World JGastroenterol 2014;20:15200-15215[PMID:25386069 DOI:10.3748/wjg.v20.i41.15200]
23 Mylona V,Koussoulas V,Tzivras D,Makrygiannis E,Georgopoulou P,Koratzanis G,GiamarellosBourboulis EJ,Tzivras MD.Changes in adaptive and innate immunity in patients with acute pancreatitis and systemic inflammatory response syndrome.Pancreatology 2011;11:475-481[PMID:21997439 DOI:10.1159/000329460]
24 Guo Y,Patil NK,Luan L,Bohannon JK,Sherwood ER.The biology of natural killer cells during sepsis.Immunology 2018;153:190-202[PMID:29064085 DOI:10.1111/imm.12854]
25 Xue J,Sharma V,Habtezion A.Immune cells and immune-based therapy in pancreatitis.Immunol Res2014;58:378-386[PMID:24710635 DOI:10.1007/s12026-014-8504-5]
26 Shrivastava P,Bhatia M.Essential role of monocytes and macrophages in the progression of acute pancreatitis.World J Gastroenterol 2010;16:3995-4002[PMID:20731012 DOI:10.3748/wjg.v16.i32.3995]
27 Oezcueruemez-Porsch M,Kunz D,Hardt PD,Fadgyas T,Kress O,Schulz HU,Schnell-Kretschmer H,Temme H,Westphal S,Luley C,Kloer HU.Diagnostic relevance of interleukin pattern,acute-phase proteins,and procalcitonin in early phase of post-ERCP pancreatitis.Dig Dis Sci 1998;43:1763-1769[PMID:9724166 DOI:10.1023/A:1018887704337]
2 Dumonceau JM,Andriulli A,Elmunzer BJ,Mariani A,Meister T,Deviere J,Marek T,Baron TH,Hassan C,Testoni PA,Kapral C;European Society of Gastrointestinal Endoscopy.Prophylaxis of post-ERCPpancreatitis:European Society of Gastrointestinal Endoscopy(ESGE)Guideline-updated June 2014.Endoscopy 2014;46:799-815[PMID:25148137 DOI:10.1055/s-0034-1377875]
3 Testoni PA,Vailati C,Giussani A,Notaristefano C,Mariani A.ERCP-induced and non-ERCP-induced acute pancreatitis:Two distinct clinical entities with different outcomes in mild and severe form?Dig Liver Dis 2010;42:567-570[PMID:20018574 DOI:10.1016/j.dld.2009.10.008]
4 Sinha A,Cader R,Akshintala VS,Hutfless SM,Zaheer A,Khan VN,Khashab MA,Lennon AM,Kalloo AN,Singh VK.Systemic inflammatory response syndrome between 24 and 48 h after ERCP predicts prolonged length of stay in patients with post-ERCP pancreatitis:a retrospective study.Pancreatology2015;15:105-110[PMID:25728146 DOI:10.1016/j.pan.2015.02.005]
5 Plavsic I,?itini?I,Mikolasevic I,Poropat G,Hauser G.Endoscopic retrograde cholangiopancreatography-induced and non-endoscopic retrograde cholangiopancreatography-induced acute pancreatitis:Two distinct clinical and immunological entities?World J Gastrointest Endosc 2018;10:259-266[PMID:30364685 DOI:10.4253/wjge.v10.i10.259]
6 Messmann H,Vogt W,Holstege A,Lock G,Heinisch A,von Fürstenberg A,Leser HG,Zirngibl H,Sch?lmerich J.Post-ERP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis.Gut 1997;40:80-85[PMID:9155580 DOI:10.1136/gut.40.1.80]
7 Minkov GA,Halacheva KS,Yovtchev YP,Gulubova MV.Pathophysiological mechanisms of acute pancreatitis define inflammatory markers of clinical prognosis.Pancreas 2015;44:713-717[PMID:26061557 DOI:10.1097/MPA.0000000000000329]
8 Pérez S,Pereda J,Sabater L,Sastre J.Redox signaling in acute pancreatitis.Redox Biol 2015;5:1-14[PMID:25778551 DOI:10.1016/j.redox.2015.01.014]
9 Kilciler G,Musabak U,Bagci S,Yesilova Z,Tuzun A,Uygun A,Gulsen M,Oren S,Oktenli C,Karaeren N.Do the changes in the serum levels of IL-2,IL-4,TNFalpha,and IL-6 reflect the inflammatory activity in the patients with post-ERCP pancreatitis?Clin Dev Immunol 2008;2008:481560[PMID:18670651DOI:10.1155/2008/481560]
10 Concepción-Martín M,Gómez-Oliva C,Juanes A,Mora J,Vidal S,Díez X,Torras X,Sainz S,Villanueva C,FarréA,Guarner-Argente C,Guarner C.IL-6,IL-10 and TNFαdo not improve early detection of post-endoscopic retrograde cholangiopancreatography acute pancreatitis:a prospective cohort study.Sci Rep 2016;6:33492[PMID:27642079 DOI:10.1038/srep33492]
11 Fung AS,Tsiotos GG,Sarr MG.ERCP-induced acute necrotizing pancreatitis:is it a more severe disease?Pancreas 1997;15:217-221[PMID:9336783 DOI:10.1097/00006676-199710000-00001]
12 Abid GH,Siriwardana HP,Holt A,Ammori BJ.Mild ERCP-induced and non-ERCP-related acute pancreatitis:two distinct clinical entities?J Gastroenterol 2007;42:146-151[PMID:17351804 DOI:10.1007/s00535-006-1979-7]
13 Mentula P,Kyl?np??-B?ck ML,Kemppainen E,Takala A,Jansson SE,Kautiainen H,Puolakkainen P,Haapiainen R,Repo H.Decreased HLA(human leucocyte antigen)-DR expression on peripheral blood monocytes predicts the development of organ failure in patients with acute pancreatitis.Clin Sci(Lond)2003;105:409-417[PMID:12780344 DOI:10.1042/CS20030058]
14 Pezzilli R,Billi P,Gullo L,Beltrandi E,Maldini M,Mancini R,Incorvaia L,Miglioli M.Behavior of serum soluble interleukin-2 receptor,soluble CD8 and soluble CD4 in the early phases of acute pancreatitis.Digestion 1994;55:268-273[PMID:8063032 DOI:10.1159/000201159]
15 Demols A,Deviere J.New frontiers in the pharmacological prevention of post-ERCP pancreatitis:the cytokines.JOP 2003;4:49-57[PMID:12555016]
16 Dabrowski A,Osada J,Dabrowska MI,Wereszczynska-Siemiatkowska U.Monocyte subsets and natural killer cells in acute pancreatitis.Pancreatology 2008;8:126-134[PMID:18382098 DOI:10.1159/000123605]
17 Mentula P,Kyl?np??ML,Kemppainen E,Jansson SE,Sarna S,Puolakkainen P,Haapiainen R,Repo H.Early prediction of organ failure by combined markers in patients with acute pancreatitis.Br J Surg 2005;92:68-75[PMID:15521080 DOI:10.1002/bjs.4786]
18 Devière J,Le Moine O,Van Laethem JL,Eisendrath P,Ghilain A,Severs N,Cohard M.Interleukin 10reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography.Gastroenterology 2001;120:498-505[PMID:11159890 DOI:10.1053/gast.2001.21172]
19 Dumot JA,Conwell DL,Zuccaro G,Vargo JJ,Shay SS,Easley KA,Ponsky JL.A randomized,double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis.Am J Gastroenterol 2001;96:2098-2102[PMID:11467638 DOI:10.1111/j.1572-0241.2001.04092.x]
20 Norman JG,Fink G,Franz M,Guffey J,Carter G,Davison B,Sexton C,Glaccum M.Active interleukin-1 receptor required for maximal progression of acute pancreatitis.Ann Surg 1996;223:163-169[PMID:8597510 DOI:10.1097/00000658-199602000-00008]
21 Brivet FG,Emilie D,Galanaud P.Pro-and anti-inflammatory cytokines during acute severe pancreatitis:an early and sustained response,although unpredictable of death.Parisian Study Group on Acute Pancreatitis.Crit Care Med 1999;27:749-755[PMID:10321665 DOI:10.1097/00003246-199904000-00029]
22 Akinosoglou K,Gogos C.Immune-modulating therapy in acute pancreatitis:fact or fiction.World JGastroenterol 2014;20:15200-15215[PMID:25386069 DOI:10.3748/wjg.v20.i41.15200]
23 Mylona V,Koussoulas V,Tzivras D,Makrygiannis E,Georgopoulou P,Koratzanis G,GiamarellosBourboulis EJ,Tzivras MD.Changes in adaptive and innate immunity in patients with acute pancreatitis and systemic inflammatory response syndrome.Pancreatology 2011;11:475-481[PMID:21997439 DOI:10.1159/000329460]
24 Guo Y,Patil NK,Luan L,Bohannon JK,Sherwood ER.The biology of natural killer cells during sepsis.Immunology 2018;153:190-202[PMID:29064085 DOI:10.1111/imm.12854]
25 Xue J,Sharma V,Habtezion A.Immune cells and immune-based therapy in pancreatitis.Immunol Res2014;58:378-386[PMID:24710635 DOI:10.1007/s12026-014-8504-5]
26 Shrivastava P,Bhatia M.Essential role of monocytes and macrophages in the progression of acute pancreatitis.World J Gastroenterol 2010;16:3995-4002[PMID:20731012 DOI:10.3748/wjg.v16.i32.3995]
27 Oezcueruemez-Porsch M,Kunz D,Hardt PD,Fadgyas T,Kress O,Schulz HU,Schnell-Kretschmer H,Temme H,Westphal S,Luley C,Kloer HU.Diagnostic relevance of interleukin pattern,acute-phase proteins,and procalcitonin in early phase of post-ERCP pancreatitis.Dig Dis Sci 1998;43:1763-1769[PMID:9724166 DOI:10.1023/A:1018887704337]